Vitamin D Controls Tumor Growth and CD8+ T Cell Infiltration in Breast Cancer

Abstract

Women with low levels of vitamin D have a higher risk of developing breast cancer. Numerous studies associated the presence of a CD8+ T cell infiltration with a good prognosis. As vitamin D may play a key role in the modulation of the immune system, the objective of this work was to evaluate the impact of vitamin D on the breast cancer progression and mammary tumor microenvironment. We show that vitamin D decreases breast cancer tumor growth. Immunomonitoring of the different immune subsets in dissociated tumors revealed an increase in tumor infiltrating CD8+ T cells in the vitamin D-treated group. Interestingly, these CD8+ T cells exhibited a more active T cell (T EM/CM ) phenotype. However, in high-fat diet conditions, we observed an opposite effect of vitamin D on breast cancer tumor growth, associated with a reduction of CD8+ T cell infiltration. Our data show that vitamin D is able to modulate breast cancer tumor growth and inflammation in the tumor microenvironment in vivo . Unexpectedly, this effect is reversed in high-fat diet conditions, revealing the importance of diet on tumor growth. We believe that supplementation with vitamin D can in certain conditions represent a new adjuvant in the treatment of breast cancers.

mTOR Links Tumor Immunity and Bone Metabolism: What are the Clinical Implications?

“…In the arm of patients treated only with exemestane, increases in the levels of bone resorption and formation markers were recorded at weeks 6 and 12 compared to baseline. Meanwhile, in the combination arm, there was a decrease in these levels of bone markers, and the effects of everolimus were not influenced by the use of bisphosphonate [58]. The phase IIIb 4EVER study evaluated the combination everolimus/exemestane in postmenopausal patients with HR positive/HER2 negative metastatic breast cancer in terms of efficacy, safety, and quality of life in a large patient population, i.e., without limitations on the number of previous chemotherapy lines, the time point of progression after nonsteroidal aromatase inhibitors, and previous exemestane.…”

Host nutritional status affects alphavirus virulence, transmission, and evolution

“…These custom diets were designed to vary as little as possible from one another except for macronutrient ratios. The obesogenic diet was a slightly modified version of a standard high-fat diet that has been used previously [36]. Four-week-old mice were fed the diets for 8 and 10 weeks.…”

EO771, is it a well‐characterized cell line for mouse mammary cancer model? Limit and uncertainty

“…The accumulation of CD8 + T lymphocytes, which may involve IGFBP‐3 (Insulin‐like Growth Factor Binding Protein‐3), is an immune population with a strong antitumor role as shown by the decrease in tumor growth 51 . Experiments inducing a CD8 + T cell depletion exacerbates EO771 tumor growth, emphasizing the importance of CD8 + T cells in controlling tumor growth 71 . Within CD4 + cells, the proportions of population subtypes evolve during tumor development with, in the early stages, a predominant Th1 lymphocyte population, known to stimulate antitumor immune responses, and then evolve into subtypes of Treg, associated with a tolerogenic profile, and Th17 cells, in more advanced stages 72 …”